Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Nickerson

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 1, 2022
Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantationPeter W Nickerson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
What have we learned about how to prevent and treat antibody-mediated rejection in kidney transplantation?Peter W Nickerson
Current Opinion in Organ Transplantation|December 3, 2019
Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipientsChris Wiebe, Peter W Nickerson
Current Opinion in Nephrology and Hypertension|September 5, 2020
More precise donor-recipient matching: the role of eplet matchingChris Wiebe, Peter W Nickerson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2026
Reply to Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study"Arjang Djamali, Peter W Nickerson
Human Immunology|December 10, 2021
Role of HLA molecular mismatch in clinical practiceChris Wiebe, Peter W Nickerson
Journal of the American Society of Nephrology : JASN|September 2, 2020
Molecular Mismatch-the Renaissance of HLA in Kidney TransplantationChris Wiebe, Peter W Nickerson
Transplantation|December 23, 2017
The Cutting Edge of HLA DiagnosticsElaine F Reed, Peter W Nickerson
Journal of the American Society of Nephrology : JASN|January 4, 2015
Begin at the Beginning to Prevent the EndPeter W Nickerson, David N Rush
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 3, 2022
Molecular Mismatch and the Risk for T Cell-Mediated RejectionChris Wiebe, Peter W Nickerson, Vasilis Kosmoliaptsis
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 1, 2022
Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantationPeter W Nickerson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2020
What have we learned about how to prevent and treat antibody-mediated rejection in kidney transplantation?Peter W Nickerson
Current Opinion in Organ Transplantation|December 3, 2019
Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipientsChris Wiebe, Peter W Nickerson
Current Opinion in Nephrology and Hypertension|September 5, 2020
More precise donor-recipient matching: the role of eplet matchingChris Wiebe, Peter W Nickerson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2026
Reply to Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study"Arjang Djamali, Peter W Nickerson
Human Immunology|December 10, 2021
Role of HLA molecular mismatch in clinical practiceChris Wiebe, Peter W Nickerson
Journal of the American Society of Nephrology : JASN|September 2, 2020
Molecular Mismatch-the Renaissance of HLA in Kidney TransplantationChris Wiebe, Peter W Nickerson
Transplantation|December 23, 2017
The Cutting Edge of HLA DiagnosticsElaine F Reed, Peter W Nickerson
Journal of the American Society of Nephrology : JASN|January 4, 2015
Begin at the Beginning to Prevent the EndPeter W Nickerson, David N Rush
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 3, 2022
Molecular Mismatch and the Risk for T Cell-Mediated RejectionChris Wiebe, Peter W Nickerson, Vasilis Kosmoliaptsis
Pageof 7